Knobbe Martens

Knobbe Martens Knobbe Martens is a highly respected intellectual property law firm, offering legal services in all aspects of intellectual property and technology law.

As a leading intellectual property and technology law firm, clients worldwide rely on Knobbe Martens to safeguard their products, brands, and technologies through strategic counsel and high-impact litigation. The firm’s litigation group handles cases throughout the U.S. and coordinates strategy for disputes worldwide. Founded in California in 1962, the firm has about 300 lawyers and scientists base

d in offices located in Orange County, Los Angeles, New York, San Diego, San Francisco, Seattle and Washington D.C. Knobbe Martens serves a diverse international client base, from multinational corporations to emerging businesses of all stages. More information about the firm can be found at www.knobbe.com.

As solar innovation accelerates globally, intellectual property strategy is becoming an increasingly critical factor in ...
05/28/2026

As solar innovation accelerates globally, intellectual property strategy is becoming an increasingly critical factor in maintaining a competitive edge.

In our latest Energy Blog post, Michael Salamy examines recent developments shaping the solar IP landscape in the U.S. and China. Michael also explores key considerations for companies operating across the solar supply chain, from patent landscape analysis to international patent strategy.

Read more here: https://www.knobbe.com/blog/the-solar-ip-landscape-in-the-u-s-and-china-is-heating-up/

In a recent MLex article on The Sedona Conference’s model jury instructions for federal litigation under the Defend Trad...
05/28/2026

In a recent MLex article on The Sedona Conference’s model jury instructions for federal litigation under the Defend Trade Secrets Act (DTSA), Knobbe Martens’ Litigation practice chair Sheila Swaroop shared insights on how the new guidance may shape litigation strategy and case framing for plaintiffs and defendants in trade secret disputes.

Read Sheila’s full comments and find a link to the article, “New DTSA Jury Instructions Aim to Bring Order to Growing Trade Secret Docket”, here: https://www.knobbe.com/updates/sheila-swaroop-quoted-in-mlex-on-sedona-conference-model-jury-instructions-for-dtsa-federal-trade-secret-litigation/

Knobbe Martens is excited to share that the firm and two dozen partners were recognized in the 2026 edition of the “IAM ...
05/28/2026

Knobbe Martens is excited to share that the firm and two dozen partners were recognized in the 2026 edition of the “IAM Patent 1000: The World’s Leading Patent Professionals” guide.

The firm received top national and regional rankings in patent prosecution, transactions, and litigation, with partners across our offices in California, Seattle, and Washington, D.C. singled out for distinction.

Reflecting the firm’s depth of talent across patent law, IAM lauded Knobbe Martens’ strengths in “patent portfolio building…high-stakes [litigation], and IP-heavy transactional work,” and praised the firm’s “expansive and highly integrated” platform.

Read more and find the firm’s full IAM Patent 1000 profile here: https://www.knobbe.com/updates/dozens-of-knobbe-martens-partners-recognized-in-2026-iam-patent-1000-guide/

The USPTO’s new PIER Pilot Program introduces a significant procedural change for certain PCT national stage application...
05/27/2026

The USPTO’s new PIER Pilot Program introduces a significant procedural change for certain PCT national stage applications, including the creation of a new pre-examination decision point that could impact patent strategy, timing, and portfolio management.

In our recent client alert, patent strategy and prosecution partner Robert Hilton examines how the program works, which applications may be affected, and key considerations for applicants navigating the new process.

Read the full alert “USPTO Launches PIER Pilot Program Creating New Pre-Examination Decision Point for PCT National Stage Applications” here: https://www.knobbe.com/updates/uspto-launches-pier-pilot-program-creating-new-pre-examination-decision-point-for-pct-national-stage-applications/

Johnson & Johnson has entered into an agreement to acquire Atraverse Medical, a company in the cardiovascular medical de...
05/26/2026

Johnson & Johnson has entered into an agreement to acquire Atraverse Medical, a company in the cardiovascular medical device sector, for an undisclosed amount.

In our latest Medical Device Blog post, Matthew Whitehead examines the planned acquisition and what it signals for the evolving cardiac device landscape.

Read more here: https://www.knobbe.com/blog/johnson-johnson-to-acquire-atraverse-medical/

Memorial Day is a time to honor and remember the individuals who gave their lives in service to our country, and whose s...
05/25/2026

Memorial Day is a time to honor and remember the individuals who gave their lives in service to our country, and whose sacrifices safeguard the freedoms that shape our daily lives.

Knobbe Martens joins with others in our communities to pause and reflect on this day, remembering those who gave everything and recognizing the responsibility we share to carry their legacy forward with purpose and integrity.

On Harvey Milk Day, we join with others throughout California and across the country to honor the legacy of Harvey Milk ...
05/22/2026

On Harvey Milk Day, we join with others throughout California and across the country to honor the legacy of Harvey Milk — a pioneering public servant whose advocacy for visibility, equality, and representation helped reshape the national conversation around LGBTQ+ rights.

Milk understood that progress depends on people being able to bring their full identities into public life, workplaces, and communities. That principle continues to resonate across industries today, including STEM fields and intellectual property, where diverse perspectives strengthen creativity, problem-solving, and advancement.

As we reflect on his enduring impact, we also recognize the importance of fostering environments where innovators, creators, and entrepreneurs from all backgrounds have the opportunity to contribute and lead. Recent research reinforces this connection, linking LGBTQ-inclusive workplace policies to stronger innovation outcomes, including increased patent activity and higher-quality patents: https://www.eurekalert.org/news-releases/1087777

As innovation accelerates in the advanced air mobility space, particularly around eVTOL aircraft, aligning regulatory st...
05/21/2026

As innovation accelerates in the advanced air mobility space, particularly around eVTOL aircraft, aligning regulatory strategy with intellectual property protection will be critical to gaining—and maintaining—a competitive edge.

In our latest Aerospace Blog post, Jeremy Johansen explores how companies can navigate evolving FAA certification pathways, shifting regulatory frameworks, and an increasingly competitive IP landscape.

Read more: https://www.knobbe.com/blog/evtol-takes-flight-navigating-certification-regulation-and-ip-in-advanced-air-mobility/

A team from Knobbe Martens secured a substantial appellate victory today on behalf of pharmaceutical manufacturer Lupin ...
05/21/2026

A team from Knobbe Martens secured a substantial appellate victory today on behalf of pharmaceutical manufacturer Lupin in Hatch-Waxman litigation involving Jynarque® (tolvaptan), a treatment for a life-threatening kidney disease.

The decision affirmed a ruling that Lupin’s proposed generic products did not infringe the asserted patents, clearing the way for more cost-effective treatment options for patients in the U.S.

The Knobbe Martens team representing Lupin was led by William Zimmerman and Carol Pitzel Cruz, Co-Chairs of the firm’s Hatch-Waxman Litigation practice, and litigation partner Jared Bunker.

Read more about the decision and the case here: https://www.knobbe.com/updates/knobbe-martens-delivers-federal-circuit-win-for-lupin-in-hatch-waxman-dispute-involving-kidney-disease-drug/

05/21/2026

In the latest episode of the Knobbe IP+ Podcast, ITC Litigation Co-Chairs Jonathan Bachand and Sheila Swaroop break down some of the most common questions around IP enforcement at the International Trade Commission.

Who should consider the ITC—and why? How do exclusion orders compare to district court injunctions? And what does the Federal Circuit’s Lashify decision mean for the domestic industry requirement?

Jon and Sheila cover these issues and more, including the ITC’s recently proposed litigation funding disclosure requirement, and offer practical insights for in-house counsel and IP professionals considering their enforcement strategies.

Find the full episode here: https://www.knobbe.com/blog/winning-strategies-for-ip-enforcement-at-the-u-s-international-trade-commission/.

Congratulations to partners Sheila Swaroop, Brian Horne, and Joseph Re on their recognitions in Daily Journal’s 2026 Top...
05/20/2026

Congratulations to partners Sheila Swaroop, Brian Horne, and Joseph Re on their recognitions in Daily Journal’s 2026 Top Intellectual Property Lawyers list.

Reflecting the firm’s strength in high-stakes litigation, each was honored for decades-long careers representing clients in complex intellectual property disputes involving cutting-edge technologies.

Read more here: https://www.knobbe.com/updates/three-knobbe-martens-partners-named-among-top-ip-lawyers-in-california-by-daily-journal/

Address

2040 Main Street, Fl 14
Irvine, CA
92614

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Knobbe Martens posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category